Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | ICMT | O60725 | 6/20 | 0.52 |
| ▸ | CCR8 | P51685 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.47 |
| ▸ | F2RL3 | Q96RI0 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | PPARG | P37231 | 1/20 | 0.45 |
| ▸ | PPARD | Q03181 | 1/20 | 0.45 |
| ▸ | PPARA | Q07869 | 1/20 | 0.45 |
| ▸ | FNTA | P49354 | 2/20 | 0.45 |
| ▸ | FNTB | P49356 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8173457 | 0.91 | PLA2G2A (0.55) | LMNAALDH1A1ICMTL3MBTL1SMN1; SMN2 | |
| SCHEMBL13931027 | 0.90 | ICMT (0.54) | LMNAALDH1A1ICMTL3MBTL1PLA2G2A | |
| SCHEMBL8172638 | 0.87 | ICMT (0.48) | LMNAALDH1A1ICMTL3MBTL1PLA2G2A | |
| SCHEMBL13931023 | 0.87 | LMNA (0.71) | LMNAALDH1A1ICMTSMN1; SMN2PLA2G2A | |
| SCHEMBL8166587 | 0.86 | CHRNB2 (0.60) | LMNAALDH1A1ICMTL3MBTL1SMN1; SMN2 | |
| SCHEMBL8187802 | 0.85 | FNTA (0.59) | LMNAALDH1A1ICMTL3MBTL1SMN1; SMN2 | |
| SCHEMBL8178890 | 0.85 | ICMT (0.47) | LMNAALDH1A1ICMTL3MBTL1SMN1; SMN2 | |
| SCHEMBL13931031 | 0.84 | LMNA (0.53) | LMNAALDH1A1ICMTL3MBTL1SMN1; SMN2 | |
| SCHEMBL13931030 | 0.84 | LMNA (0.53) | LMNAALDH1A1ICMTL3MBTL1SMN1; SMN2 | |
| SCHEMBL8180741 | 0.84 | KMT2A (0.52) | LMNAALDH1A1ICMTL3MBTL1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090047246-A1 | NOVEL INHIBITORS OF HEPATITIS C VIRUS REPLICATION | INTERMUNE, INC. (US) | 2009-02-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090047246-A1 | NOVEL INHIBITORS OF HEPATITIS C VIRUS REPLICATION | EIF2AK2, HAVCR2, HCCS | LMNA 2969/4885ALDH1A1 1836/4885ICMT 2415/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.